NEW YORK (MedscapeWire) May 23 — Lamotrigine (Lamictal) has distinct and perhaps complementary mood-stabilizing effects for the treatment of bipolar disorder, according to presentations on May 20 and ...
September 6, 2006 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for ciprofloxacin 200-mg/20-mL, 400-mg/40-mL, and 1200-mg/20-mL single-dose vials in the ...
LOS ANGELES -- The FDA's warning about arrhythmia risk with lamotrigine (Lamictal) based on in vitro data wasn't borne out in observational cohorts of people with epilepsy, although the risk did ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback